Misiu is on point with everything she said on HCQ/ZPak over the past 2 weeks. NY banned it for non FDA approved, non hospital, non trial use. That includes mild CV positives in a outpatient setting and prophylaxis for healthcare workers. Once you are hospitalized, it may not be useful and may cause harm.
Then it is time for leronlimab.

It is these outpatients who are spreading the virus who need it the most.